CTRI

Â· Pulp vitality is an important aspect in determining a tooth’s long-term health and survival, as exposed vital pulp has an intrinsic capacity for healing. By eliminating contaminated tissue and promoting dentin bridge formation with a minimally invasive approach: Vital Pulp Therapy works to preserve and protect the pulpal vitality of a tooth that has undergone mutilating factors such as dental caries, trauma, and operative failure, especially when pulp inflammation is limited to the outermost layers and the deeper layers are healthy. Although root canal therapy is well recognized to produce reliable results, it leaves teeth prone to fracture, and it would be preferable to provide patients with an alternative minimal invasive approach. Hence the argument for vital pulp therapy is that radicular pulp tissue is healthy or capable of recovering after surgical amputation of the damaged or contaminated coronal pulp.^1,2,3

Â· Direct pulp capping, which includes applying a protective pulp capping material directly over the exposure location, is typically indicated in a recent exposure of pulp that is pinpoint-sized. Indirect pulp capping is a treatment in which non-mineralizable carious tissue is removed, leaving a thin layer of remaining sound dentin at the deepest site of the cavity to prevent pulp exposure and the caries affected dentin is capped with suitable biocompatible material. In contrast, pulpotomy is described as the partial removal of the pulp (coronal component) while keeping the radicular pulp intact after establishing adequate hemostasis and restoration done with biocompatible materials.^4,5

Â· Despite recent technological advancements in dental materials, like improved biocompatibility, regenerative dentin capacity, bioactivity, fast setting time and decreased solubility, there still remains a quest for the perfect vital pulp therapy agent. Furthermore, research is currently ongoing in order to achieve the greatest possible clinical and radiographic success in permanent dentitions and the demand for better medications has opened the door for more clinical investigations to explore the effectiveness rate of Vital Pulp Therapy (VPT) in teeth using various protocols.^7,8

Â· Mineral Trioxide Aggregate (MTA) is a calcium silicate-based cement, developed by Torabinejad that has been extensively researched and reported to provide high success rates(~90%) of treatment outcomes in vital pulp therapy .It is composed of portland cement (75%), bismuth oxide (20%) and gypsum (5%). Portland cement is a combination of tricalcium silicate, dicalcium silicate, tricalium aluminate & tetracalciumaluminoferrite. In comparison to calcium oxide, it has many advantages including a homogenous dentinal bridge formation with fewer tunnel defects, sustained calcium release, biocompatibility, sealing ability, long-term stability, low solubility, hygroscopic nature, excellent sealing ability, solubilization of bioactive proteins, and ability for tissue remineralization. Although MTA has a greater success rate, the disadvantages of this material, including its high cost, technique sensitivity, longer setting time, potential for tooth discoloration and inclusion of poisonous heavy metals, have led researchers to hunt for other materials. Yet numerous studies have used MTA as a gold standard medicament in vital pulp therapy.^9,10

Â· Biodentine, a bioactive dentine substitute, composed of Tricalcium Silicate(80%), with Zirconium oxide as a radio-opacifier, calcium carbonate(15%) as a filler and water as setting accelerator of Calcium Chloride. It has been reported to have superior mechanical properties like better color stability, easier handling and manipulation and fast setting time. Its major drawbacks are low radioopacity and difficulty in maintaining a specific consistency.^9,10,11,12

Theracal LC (Bisco,USA) was introduced to address the lack of adhesion between the resins and calcium silicate based materials in final restorations. Theracal LC is a calcium silicate filled, light-cured liner which provides an insulative and protective layer for pulp-dentin complex. Theracal LC releases calcium which enhances development of hydroxyapatite which in turn forms dentine bridge. It has superior bonding capacity compared to composite and glass-ionomer cement with a significant bioactivity.Additional research is required to estimate its efficacy over a longer period of time. The newly developed materials have the ability to stimulate the pulp progenitor cells in an improved manner and there is ever growing demand for new developments of bioactive materials for Vital pulp Therapy (VPT). However, their long term success in permanent teeth still needs to be supported by further research.

There have been studies which have been conducted in- vitro and most of them are in primary dentition. However, there are quite limited In-Vivo studies and case reports which have been done on Permanent teeth to substantiate the effects of MTA, Biodentine and Theracal LC and compare their clinical efficacy and radiographical analysis in contrast with each other under different vital pulp therapy procedures.The purpose of this study is to provide comparison between these bioactive materials of choice in Vital Pulp Therapy in treatment of permanent teeth with symptomatic pulpitis.